Global biotech company CSL Limited will supply the Australian Government with 51 million
doses of The Un
iversity of Queensland’s COVID-19 vaccine candidate if it proves successful, under a heads of agreement announced today.
CSL expects the first tranche of doses to be available by mid-2021, with additional doses following in late 2021 and early 2022, if late stage clinical trials are successful.
